Correction: Cost‑effectiveness of finerenone in chronic kidney disease associated with type 2 diabetes in The Netherlands

Saved in:
Bibliographic Details
Main Authors: Sara W. Quist, Alexander V. van Schoonhoven, Stephan J. L. Bakker, Michał Pochopień, Maarten J. Postma, Jeanni M. T. van Loon, Jeroen H. J. Paulissen
Format: Article
Language:English
Published: BMC 2025-05-01
Series:Cardiovascular Diabetology
Online Access:https://doi.org/10.1186/s12933-025-02752-2
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849309732977770496
author Sara W. Quist
Alexander V. van Schoonhoven
Stephan J. L. Bakker
Michał Pochopień
Maarten J. Postma
Jeanni M. T. van Loon
Jeroen H. J. Paulissen
author_facet Sara W. Quist
Alexander V. van Schoonhoven
Stephan J. L. Bakker
Michał Pochopień
Maarten J. Postma
Jeanni M. T. van Loon
Jeroen H. J. Paulissen
author_sort Sara W. Quist
collection DOAJ
format Article
id doaj-art-7d2ce460a7b6460bba5690bd1914ade1
institution Kabale University
issn 1475-2840
language English
publishDate 2025-05-01
publisher BMC
record_format Article
series Cardiovascular Diabetology
spelling doaj-art-7d2ce460a7b6460bba5690bd1914ade12025-08-20T03:53:58ZengBMCCardiovascular Diabetology1475-28402025-05-012411310.1186/s12933-025-02752-2Correction: Cost‑effectiveness of finerenone in chronic kidney disease associated with type 2 diabetes in The NetherlandsSara W. Quist0Alexander V. van Schoonhoven1Stephan J. L. Bakker2Michał Pochopień3Maarten J. Postma4Jeanni M. T. van Loon5Jeroen H. J. Paulissen6Department of Health Sciences, University of GroningenDepartment of Health Sciences, University of Groningen Division of Nephrology, Department of Internal Medicine, University Hospital GroningenAssignityDepartment of Health Sciences, University of GroningenValue-XSDepartment of Health Sciences, University of Groningenhttps://doi.org/10.1186/s12933-025-02752-2
spellingShingle Sara W. Quist
Alexander V. van Schoonhoven
Stephan J. L. Bakker
Michał Pochopień
Maarten J. Postma
Jeanni M. T. van Loon
Jeroen H. J. Paulissen
Correction: Cost‑effectiveness of finerenone in chronic kidney disease associated with type 2 diabetes in The Netherlands
Cardiovascular Diabetology
title Correction: Cost‑effectiveness of finerenone in chronic kidney disease associated with type 2 diabetes in The Netherlands
title_full Correction: Cost‑effectiveness of finerenone in chronic kidney disease associated with type 2 diabetes in The Netherlands
title_fullStr Correction: Cost‑effectiveness of finerenone in chronic kidney disease associated with type 2 diabetes in The Netherlands
title_full_unstemmed Correction: Cost‑effectiveness of finerenone in chronic kidney disease associated with type 2 diabetes in The Netherlands
title_short Correction: Cost‑effectiveness of finerenone in chronic kidney disease associated with type 2 diabetes in The Netherlands
title_sort correction cost effectiveness of finerenone in chronic kidney disease associated with type 2 diabetes in the netherlands
url https://doi.org/10.1186/s12933-025-02752-2
work_keys_str_mv AT sarawquist correctioncosteffectivenessoffinerenoneinchronickidneydiseaseassociatedwithtype2diabetesinthenetherlands
AT alexandervvanschoonhoven correctioncosteffectivenessoffinerenoneinchronickidneydiseaseassociatedwithtype2diabetesinthenetherlands
AT stephanjlbakker correctioncosteffectivenessoffinerenoneinchronickidneydiseaseassociatedwithtype2diabetesinthenetherlands
AT michałpochopien correctioncosteffectivenessoffinerenoneinchronickidneydiseaseassociatedwithtype2diabetesinthenetherlands
AT maartenjpostma correctioncosteffectivenessoffinerenoneinchronickidneydiseaseassociatedwithtype2diabetesinthenetherlands
AT jeannimtvanloon correctioncosteffectivenessoffinerenoneinchronickidneydiseaseassociatedwithtype2diabetesinthenetherlands
AT jeroenhjpaulissen correctioncosteffectivenessoffinerenoneinchronickidneydiseaseassociatedwithtype2diabetesinthenetherlands